Knowledge (XXG)

Gliosarcoma

Source 📝

165:
evidence for the "collision tumor" hypothesis. Also, Studies demonstrating the sarcomatous component's histological sensitivity to markers of vascular endothelium such factor CD34, von Willebrand factor, and VIII supported this theory. An alternative view that has recently gained support suggests that both gliosarcoma components have a monoclonal origin, with the sarcomatous component deriving from abnormal differentiation of malignant gliomal mesenchyma. First, gliomatous and sarcomatous components were shown to have similar p53 alterations by Biernat and colleagues. In both tumor regions, Reis and colleagues found similar nuclear accumulation of p53, deletion of p16, mutations of PTEN,and amplifications of CDK4. Other scientists then noted that both gliosarcoma components had similar genetic changes and chromosomal abnormalities of the kind often seen in GBM.
37: 807: 191:
GBM and other cerebral gliomas rarely metastasize outside the brain. Numerous authors described incidences of metastatic foci that mixed gliomatous and sarcomatous components, while others reported metastatic foci that were entirely composed of the sarcomatous component. Most gliosarcoma extracranial
173:
Gliosarcoma is rare; incidence ranges from 1.8 to 2.8 percent lower than that of GBMs. PGS affects persons in their 6th to 7th years of life, and it is much more frequent in males than in females (with 1.4-1.8:1 ratio). Depending on where the tumor is located, the reported presenting signs
200:
Tumor removal, postoperative radiation treatment, and chemotherapy with nitrosureas, misonidazole, dacarbazine, temozolomide, doxorubicin , vincristine, cisplatin, mithramycin, ametophterin, thalidomide, or irinotecan have all been recorded as treatment options for gliosarcoma and radiotherapy with
182:
On CT imaging, the lesions might show as Well-defined high-density lesion edges and homogeneous enhancement, replicating the meningioma appearance, or as lesions with large necrotic regions and GBM-like heterogeneous contrast enhancement. Marked peritumoral edema is a characteristic and frequent
125:
components. Primary gliosarcoma (PGS) is classified as a grade IV tumor and a subtype of glioblastoma multiforme in the 2007 World Health Organization classification system (GBM). Because of a lack of specific and clear diagnostic criteria, the word "gliosarcoma" was frequently used to refer to
164:
Early reports claimed that the hyperplastic blood vessels that are frequently present in high grade gliomas underwent neoplastic change to become the sarcomatous components. Feigin's early reports components of perivascular sarcomatous and hyperplastic arteries in gliosarcoma offered
174:
and symptoms, such as aphasia, headaches, hemiparesis, seizures, and cognitive loss, are similar with those of a fast developing intracranial tumor. Many researchers have come to the conclusion that these tumors are clinically identical to GBM due to their clinical similarities.
702: 495:
Boerman R, Anderl K, Herath J, Borell T, Johnson N, SchaefferKlein J, Kirchof A, Raap AK, Scheithauer BW, Jenkins RB (1996) The glilal and mesenchymal elements of gliosarcomas share similar genetic alterations. J Neuropathol Exp Neurol
402:
Galanis E, Buckner JC, Dinapoli RP, Scheithauer BW, Jenkins RB, Wang CH, O’Fallon JR, Farr G Jr (1998) Clinical outcome of gliosarcoma compared with glioblastoma multiforme: north central cancer treatment group results. J Neurosurg
439:
McComb R, Jones TR, Pizzo SV, Bigner DD (1982) Immunohistochemical detection of factor VIII/von Willebrand factor in hyperplastic endothelial cells in glioblastoma multiforme and mixed glioma-sarcoma. J Neuropathol Exp Neurol
811: 645:
Rodriguez F, Scheithauer BW, Jenkins R, Burger PC, Rudzinskiy P, Vlodavsky E, Schooley A, Landolfi J (2007) Gliosarcoma arising in oligodendroglial tumors (‘‘oligosarcoma’’): a clinicopathologic study. Am J Surg Pathol
485:
Actor B, Cobbers JM, Buschges R, Wolter M, Knobbe CB, Lichter P, Reifenberger G, Weber RG (2002) Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components. Genes Chromosomes Cancer
537:
Maiuri F, Stella L, Benvenuti D, Giamundo A, Pettinato G (1990) Cerebral gliosarcomas: correlation of computed tomographic findings, surgical aspect, pathological features, and prognosis. Neurosurgery 26:261–267
467:
Biernat W, Aguzzi A, Sure U, Grant JW, Kleihues P, Hegi ME (1995) Identical mutations of the p53 tumor suppressor gene in the gliomatous and the sarcomatous components of gliosarcomas suggest a common or
1319: 1219: 937: 878: 329:
Louis D, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109
458:
Wharton S, Whittle IR, Collie DA, Bell HS, Ironside JW (2001) Gliosarcoma with areas of primitive neuroepithelial differentiation and extracranial metastasis. Clin Neuropathol 20:212–218
655:
Stupp R, Mason WP, Van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996
714: 192:
metastases are found in the lung and liver, but there have been reports of metastases elsewhere as well, including evidence of intramedullary metastases to the cervical spine.
582:
Ojeda V, Sterrett GF (1984) Cerebral gliosarcoma, pulmonary adenoid-cystic carcinoma, and pulmonary metastatic gliosarcoma: report of an untreated case. Pathology 16:217–221
519:
Machuca T, Prevedello DM, Pope LZ, Haratz SS, Araujo JC, Torres LF (2004) Gliosarcoma: report of four cases with immunohistochemical findings. Arq Neuropsiquiatr 62:608–612
430:
Feigin I, Allen LB, Lipkin L, Gross SW (1958) The endothelial hyperplasia of cerebral blood vessels with brain tumors, and its sarcomatous transformation. Cancer 2:264–277
449:
Slowik F, Jellinger K, Gaszo L, Fischer J (1985) Gliosarcomas: histological, immunohistochemical, ultrastructural, and tissue culture studies. Acta Neuropathol 67:201–210
421:
Meis J, Martz KL, Nelson JS (1990) Mixed glioblastoma multiforme and sarcoma: a clinicopathologic study of 26 radiation therapy oncology group cases. Cancer 67:2342–2349
664:
Kozak KR, Mahadevan A, Moody JS. Adult gliosarcoma: epidemiology, natural history and factors associated with outcome. April. 2009;Cancer:183–191. doi:10.1215/15228517.
850: 1182: 636:
Witwer B, Salamat MS, Resnick DK (2000) Gliosarcoma metastatic to the cervical spine cord: case report and review of the literature. Surg Neurol 54:373–379
618:
Matsuyama J, Mori T, Hori S, Nakano T, Yamada A (1989) Gliosarcoma with multiple extracranial metastases. Case report. Neurol Med Chir (Tokyo) 29:938–943
360:
Beaumont TL, Kupsky WJ, Barger GR, Sloan AE (May 2007). "Gliosarcoma with multiple extracranial metastases: case report and review of the literature".
1303: 1227: 1151: 627:
Yokoyama H, Ono H, Mori K, Kishikawa M, Kihara M (1985) Extracranial metastasis of glioblastoma with sarcomatous component. Surg Neurol 24:641–645
795: 600:
Cerame M, Guthikonda M, Kohli CM (1985) Extraneural metastases in gliosarcoma: a case report and review of literature. Neurosurgery 17:413–418
281: 591:
Weaver D, Vandenberg S, Park TS, Jane JA (1984) Selective peripancreatic sarcoma metastases from primary gliosarcoma.J Neurosurg 61:599–601
989: 843: 129:
It is estimated that approximately 2.1% of all glioblastomas are gliosarcomas. Although most gliomas rarely show metastases outside the
546:
Ehrenreich T, Devlin JF (1958) A complex of glioblastoma and spindle-cell sarcoma with pulmonary metastases. Arch Pathol 66:536–549
234: 1177: 573:
Gjedrum L, Bojsen-Moller M (1999) 61-year old male with brain tumor and oral, lung, and palpebral masses. Brain Pathol 9:421–422
412:
Parekh H, O’Donovan DG, Sharma RR, Keogh AJ (1995) Primary cerebral gliosarcoma: report of 17 cases. Br J Neurosurg 9:171–178
836: 822: 564:
Smith D, Hardman JM, Earle KM (1969) Glioblastoma multiforme and fibrosarcoma with extracranial metastasis. Cancer 24:270–276
476:
Reis R, Konu-Lebleblicioglu D, Lopes JM, Kleihues P, Ohgaki H (2000) Genetic profile of gliosarcomas. Am J Pathol 156:425–432
984: 782: 673:
Morantz R, Feigin I, Ransohoff J (1976) Clinical and pathological study of 24 cases of gliosarcoma. J Neurosurg 45:398–408
1156: 1029: 1241: 276: 210: 1080: 1075: 867: 725: 859: 214: 81: 765: 528:
Lee Y, Castillo M, Nauert C, Moser RP (1985) Computed tomography of gliosarcoma. Am J Neuroradiol 4:527–531
510:
Lutterbach J, Guttenberger R, Pagenstecher A (2001) Gliosarcoma: a clinical study. Radiother Oncol 61:57–64
1331:
Note: Not all brain tumors are of nervous tissue, and not all nervous tissue tumors are in the brain (see
999: 994: 928: 555:
Garret R (1958) Glioblastoma and fibrosarcoma of the brain with extracranial metastases. Cancer 11:888–894
609:
Slowik F, Balogh I (1980) Extracranial spreading of glioblastoma multiforme. Zentralbl Neurochir 41:57–68
1354: 1296: 1255: 979: 36: 48: 1359: 1260: 1070: 338:
Stroebe H (1895) Ueber Entstehung und Bau der Gehirnglioma. Beitr Pathol Anat Allg Pathol 19:405–486
1103: 792: 271: 209:
PGS has a poor prognosis, a prognosis of median survival of 4 months in untreated individuals. The
1267: 1209: 385: 126:
glial tumours with mesenchymal properties, such as the ability to make collagen and reticulin.
1280: 1024: 889: 377: 350:
Feigin I, Gross SW (1954) Sarcoma arising in glioblastoma of the brain. Am J Pathol 31:633–653
312: 56: 1332: 1098: 369: 133:, gliosarcomas have a propensity to do so, most commonly spreading through the blood to the 1172: 1016: 799: 786: 303:
Ayadi L, Charfi S, Khabir A, Kalle R, Sellami A, Makni S, et al. (March 2010). "".
242: 1141: 1132: 1062: 719: 61: 1348: 1250: 1136: 1052: 235:"Gliosarcoma: Genetic and Rare Diseases Information Center (GARD) – an NCATS Program" 149: 389: 1287: 1275: 1004: 947: 153: 118: 730: 1146: 974: 942: 894: 828: 779: 142: 1291: 1204: 1047: 373: 44: 966: 914: 736: 76: 381: 316: 1196: 1039: 760: 130: 122: 694: 1124: 957: 706: 114: 106: 102: 816: 117:
brain cells. Gliosarcoma is a malignant cancer, and is defined as a
138: 134: 110: 741: 832: 1320:
WHO classification of the tumors of the central nervous system
789:
entry in the public domain NCI Dictionary of Cancer Terms
684: 1312: 1240: 1218: 1195: 1165: 1121: 1091: 1061: 1038: 1015: 965: 956: 936: 927: 903: 875: 866: 751: 688: 88: 75: 67: 55: 26: 21: 113:, or supportive, brain cells, as opposed to the 844: 8: 1183:Embryonal tumour with multilayered rosettes 92:~215 new diagnoses per year (United States) 962: 953: 933: 872: 851: 837: 829: 685: 183:hallmark of gliosarcomas observed on MRI. 35: 18: 506: 504: 502: 346: 344: 1304:Malignant peripheral nerve sheath tumor 1228:Primary central nervous system lymphoma 1152:Dysembryoplastic neuroepithelial tumour 793:Gliosarcoma - National Cancer Institute 226: 284:from the original on October 11, 2021 272:"Gliosarcoma Diagnosis and Treatment" 266: 264: 262: 260: 7: 990:Subependymal giant cell astrocytoma 148:They most commonly present in the 14: 1178:Atypical teratoid rhabdoid tumor 810: This article incorporates 805: 47:showing a gliosarcoma. Elastic 1272:Cranial and paraspinal nerves 823:U.S. National Cancer Institute 1: 985:Pleomorphic xanthoastrocytoma 860:Tumours of the nervous system 217:of gliosarcoma is only 5.6%. 121:consisting of gliomatous and 109:of the brain that comes from 1030:Anaplastic oligodendroglioma 71:Between 40 and 60 years old 1376: 818:Dictionary of Cancer Terms 1328: 374:10.1007/s11060-006-9295-x 362:Journal of Neuro-Oncology 277:National Cancer Institute 239:rarediseases.info.nih.gov 213:states that the relative 211:National Cancer Institute 43: 34: 30:Sarcomatous glioblastoma 1157:Lhermitte–Duclos disease 1081:Choroid plexus carcinoma 1076:Choroid plexus papilloma 169:Clinical characteristics 215:five-year survival rate 82:Five-year survival rate 1000:Anaplastic astrocytoma 995:Fibrillary astrocytoma 812:public domain material 1256:Esthesioneuroblastoma 980:Pilocytic astrocytoma 280:. 17 September 2018. 1261:Ganglioneuroblastoma 1166:CNS embryonal tumors 1071:Choroid plexus tumor 1104:Gliomatosis cerebri 305:La Tunisie Médicale 1268:Nerve sheath tumor 1210:Hemangiopericytoma 798:2021-10-11 at the 785:2015-04-28 at the 752:External resources 101:is a rare type of 49:van Gieson's stain 1342: 1341: 1281:Neurofibromatosis 1236: 1235: 1191: 1190: 1117: 1116: 1025:Oligodendroglioma 923: 922: 890:Craniopharyngioma 775: 774: 96: 95: 16:Medical condition 1367: 1333:brain metastasis 1297:Acoustic neuroma 1099:Oligoastrocytoma 1092:Multiple/unknown 963: 954: 934: 908: 883: 873: 853: 846: 839: 830: 826: 809: 808: 686: 674: 671: 665: 662: 656: 653: 647: 643: 637: 634: 628: 625: 619: 616: 610: 607: 601: 598: 592: 589: 583: 580: 574: 571: 565: 562: 556: 553: 547: 544: 538: 535: 529: 526: 520: 517: 511: 508: 497: 493: 487: 483: 477: 474: 468: 465: 459: 456: 450: 447: 441: 437: 431: 428: 422: 419: 413: 410: 404: 400: 394: 393: 357: 351: 348: 339: 336: 330: 327: 321: 320: 300: 294: 293: 291: 289: 268: 255: 254: 252: 250: 241:. Archived from 231: 39: 19: 1375: 1374: 1370: 1369: 1368: 1366: 1365: 1364: 1345: 1344: 1343: 1338: 1337: 1324: 1308: 1232: 1214: 1187: 1173:Medulloblastoma 1161: 1123: 1113: 1087: 1057: 1034: 1017:Oligodendrocyte 1011: 946: 940: 938:Neuroepithelial 919: 904: 899: 876: 862: 857: 815: 806: 800:Wayback Machine 787:Wayback Machine 776: 771: 770: 747: 746: 697: 683: 678: 677: 672: 668: 663: 659: 654: 650: 644: 640: 635: 631: 626: 622: 617: 613: 608: 604: 599: 595: 590: 586: 581: 577: 572: 568: 563: 559: 554: 550: 545: 541: 536: 532: 527: 523: 518: 514: 509: 500: 494: 490: 484: 480: 475: 471: 466: 462: 457: 453: 448: 444: 438: 434: 429: 425: 420: 416: 411: 407: 401: 397: 359: 358: 354: 349: 342: 337: 333: 328: 324: 302: 301: 297: 287: 285: 270: 269: 258: 248: 246: 245:on 13 July 2019 233: 232: 228: 223: 207: 198: 189: 180: 171: 162: 17: 12: 11: 5: 1373: 1371: 1363: 1362: 1357: 1347: 1346: 1340: 1339: 1329: 1326: 1325: 1323: 1322: 1316: 1314: 1310: 1309: 1307: 1306: 1301: 1300: 1299: 1285: 1284: 1283: 1278: 1270: 1265: 1264: 1263: 1258: 1247: 1245: 1238: 1237: 1234: 1233: 1231: 1230: 1224: 1222: 1216: 1215: 1213: 1212: 1207: 1201: 1199: 1193: 1192: 1189: 1188: 1186: 1185: 1180: 1175: 1169: 1167: 1163: 1162: 1160: 1159: 1154: 1149: 1144: 1142:Retinoblastoma 1139: 1133:Ganglioneuroma 1129: 1127: 1119: 1118: 1115: 1114: 1112: 1111: 1106: 1101: 1095: 1093: 1089: 1088: 1086: 1085: 1084: 1083: 1078: 1067: 1065: 1063:Choroid plexus 1059: 1058: 1056: 1055: 1050: 1044: 1042: 1036: 1035: 1033: 1032: 1027: 1021: 1019: 1013: 1012: 1010: 1009: 1008: 1007: 1002: 997: 992: 987: 982: 971: 969: 960: 951: 931: 925: 924: 921: 920: 918: 917: 911: 909: 901: 900: 898: 897: 892: 886: 884: 870: 864: 863: 858: 856: 855: 848: 841: 833: 803: 802: 790: 773: 772: 769: 768: 756: 755: 753: 749: 748: 745: 744: 733: 722: 711: 698: 693: 692: 690: 689:Classification 682: 681:External links 679: 676: 675: 666: 657: 648: 638: 629: 620: 611: 602: 593: 584: 575: 566: 557: 548: 539: 530: 521: 512: 498: 488: 478: 469: 460: 451: 442: 432: 423: 414: 405: 395: 352: 340: 331: 322: 311:(3): 142–146. 295: 256: 225: 224: 222: 219: 206: 203: 201:temozolomide. 197: 194: 188: 185: 179: 176: 170: 167: 161: 158: 94: 93: 90: 86: 85: 79: 73: 72: 69: 65: 64: 62:Neuro-oncology 59: 53: 52: 41: 40: 32: 31: 28: 24: 23: 15: 13: 10: 9: 6: 4: 3: 2: 1372: 1361: 1358: 1356: 1353: 1352: 1350: 1336: 1334: 1327: 1321: 1318: 1317: 1315: 1311: 1305: 1302: 1298: 1295: 1294: 1293: 1289: 1286: 1282: 1279: 1277: 1274: 1273: 1271: 1269: 1266: 1262: 1259: 1257: 1254: 1253: 1252: 1251:Neuroblastoma 1249: 1248: 1246: 1243: 1239: 1229: 1226: 1225: 1223: 1221: 1220:Hematopoietic 1217: 1211: 1208: 1206: 1203: 1202: 1200: 1198: 1194: 1184: 1181: 1179: 1176: 1174: 1171: 1170: 1168: 1164: 1158: 1155: 1153: 1150: 1148: 1145: 1143: 1140: 1138: 1137:Ganglioglioma 1134: 1131: 1130: 1128: 1126: 1120: 1110: 1107: 1105: 1102: 1100: 1097: 1096: 1094: 1090: 1082: 1079: 1077: 1074: 1073: 1072: 1069: 1068: 1066: 1064: 1060: 1054: 1053:Subependymoma 1051: 1049: 1046: 1045: 1043: 1041: 1037: 1031: 1028: 1026: 1023: 1022: 1020: 1018: 1014: 1006: 1003: 1001: 998: 996: 993: 991: 988: 986: 983: 981: 978: 977: 976: 973: 972: 970: 968: 964: 961: 959: 955: 952: 949: 948:spinal tumors 944: 939: 935: 932: 930: 926: 916: 913: 912: 910: 907: 902: 896: 893: 891: 888: 887: 885: 882: 880: 874: 871: 869: 865: 861: 854: 849: 847: 842: 840: 835: 834: 831: 827: 824: 820: 819: 813: 801: 797: 794: 791: 788: 784: 781: 778: 777: 767: 763: 762: 758: 757: 754: 750: 743: 739: 738: 734: 732: 728: 727: 723: 721: 717: 716: 712: 709: 708: 704: 700: 699: 696: 691: 687: 680: 670: 667: 661: 658: 652: 649: 642: 639: 633: 630: 624: 621: 615: 612: 606: 603: 597: 594: 588: 585: 579: 576: 570: 567: 561: 558: 552: 549: 543: 540: 534: 531: 525: 522: 516: 513: 507: 505: 503: 499: 492: 489: 482: 479: 473: 470: 464: 461: 455: 452: 446: 443: 436: 433: 427: 424: 418: 415: 409: 406: 399: 396: 391: 387: 383: 379: 375: 371: 367: 363: 356: 353: 347: 345: 341: 335: 332: 326: 323: 318: 314: 310: 307:(in French). 306: 299: 296: 283: 279: 278: 273: 267: 265: 263: 261: 257: 244: 240: 236: 230: 227: 220: 218: 216: 212: 204: 202: 195: 193: 186: 184: 177: 175: 168: 166: 159: 157: 155: 151: 150:temporal lobe 146: 144: 140: 136: 132: 127: 124: 120: 116: 112: 108: 104: 100: 91: 87: 83: 80: 78: 74: 70: 66: 63: 60: 58: 54: 50: 46: 42: 38: 33: 29: 25: 20: 1355:Rare cancers 1330: 1288:Neurilemmoma 1276:Neurofibroma 1108: 1005:Glioblastoma 943:brain tumors 905: 877: 817: 804: 759: 735: 724: 713: 701: 669: 660: 651: 641: 632: 623: 614: 605: 596: 587: 578: 569: 560: 551: 542: 533: 524: 515: 491: 481: 472: 463: 454: 445: 435: 426: 417: 408: 398: 368:(1): 39–46. 365: 361: 355: 334: 325: 308: 304: 298: 286:. Retrieved 275: 247:. Retrieved 243:the original 238: 229: 208: 199: 190: 181: 172: 163: 160:Pathogenesis 154:frontal lobe 147: 128: 119:glioblastoma 98: 97: 1360:Brain tumor 1147:Neurocytoma 1109:Gliosarcoma 975:Astrocytoma 895:Pituicytoma 780:Gliosarcoma 143:lymph nodes 137:, and also 123:sarcomatous 99:Gliosarcoma 68:Usual onset 27:Other names 22:Gliosarcoma 1349:Categories 1292:Schwannoma 1205:Meningioma 1048:Ependymoma 646:31:351–362 496:55:973–981 486:34:416–427 440:41:479–489 403:89:425–430 221:References 187:Metastasis 45:Micrograph 967:Astrocyte 915:Pinealoma 868:Endocrine 737:SNOMED CT 205:Prognosis 196:Treatment 89:Frequency 77:Prognosis 57:Specialty 1197:Meninges 1040:Ependyma 796:Archived 783:Archived 761:Orphanet 742:35262004 390:13171064 382:17171442 317:20415184 288:March 8, 282:Archived 131:cerebrum 731:D018316 720:M9442/3 710:: G71.9 249:13 July 178:Imaging 1125:neuron 1122:Mature 958:Glioma 906:Other: 879:Sellar 766:251576 388:  380:  315:  115:neural 107:cancer 103:glioma 84:: 5.6% 1313:Other 814:from 715:ICD-O 386:S2CID 152:and 139:liver 135:lungs 111:glial 726:MeSH 378:PMID 313:PMID 290:2023 251:2019 141:and 105:, a 1242:PNS 929:CNS 703:ICD 370:doi 1351:: 1335:). 1135:: 821:. 764:: 740:: 729:: 718:: 707:10 501:^ 384:. 376:. 366:83 364:. 343:^ 309:88 274:. 259:^ 237:. 156:. 145:. 1290:/ 1244:: 950:) 945:, 941:( 881:: 852:e 845:t 838:v 825:. 705:- 695:D 392:. 372:: 319:. 292:. 253:. 51:.

Index


Micrograph
van Gieson's stain
Specialty
Neuro-oncology
Prognosis
Five-year survival rate
glioma
cancer
glial
neural
glioblastoma
sarcomatous
cerebrum
lungs
liver
lymph nodes
temporal lobe
frontal lobe
National Cancer Institute
five-year survival rate
"Gliosarcoma: Genetic and Rare Diseases Information Center (GARD) – an NCATS Program"
the original




"Gliosarcoma Diagnosis and Treatment"
National Cancer Institute
Archived

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.